Oncology
Kizfizo® (code names: Ped-TMZ or Kimozo)
Temozolomide oral suspension, 40mg/ml
Product under registration dossier review in the EU.
Kizfizo 40 mg/ml is a ready-to-use and taste-masked oral suspension of temozolomide.
Pharmaceutical form
Kizfizo is developed as a kit containing 1 bottle filled with 18 ml of temozolomide oral suspension (40mg/ml) and 1 dosing oral syringe graduated up to 5 ml with a 0.1 ml dosing increment.
Unmet medical need in pediatric patients
Kizfizo has been specifically developed as a liquid, ready-to-use and taste-masked oral suspension to fully address the needs of pediatric patients in line with EMA recommendations(1).